查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575726

心输出量监测仪市场 - 2024-2031

Cardiac Output Monitors Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球心输出量监测仪市场规模达15亿美元，预计2031年将达22.3亿美元，2024-2031年预测期间复合年增长率为5.2%。

心输出量监测仪在临床医学中发挥着至关重要的作用，特别是在重症监护和心臟病学环境中，因为它们提供有关患者心血管功能的重要资讯。心输出量监测的重要性在于它能够帮助医疗保健提供者就病患管理和治疗做出明智的决策。心输出量监测允许客製化患者治疗策略。

透过根据患者的个别心血管需求调整治疗方法，医疗专业人员可以优化患者的治疗效果。心臟衰竭患者经常需要密切心输出量监测，以评估治疗效果并避免失代偿。透过早期辨识和治疗血流动力学不稳定，可以避免器官衰竭、组织缺氧和延长住院时间。

市场动态：

司机

心血管疾病盛行率增加

心血管疾病盛行率的上升推动了市场的成长。由于心血管疾病和病症的盛行率不断上升，需要改进监测和管理技术，包括心输出量监测器。由于心血管疾病的增加，市场正在迅速扩大。例如，根据美国疾病管制与预防中心的数据，心臟病是美国男性、女性以及大多数种族和族裔群体的首要死因。在美国，每 33 秒就有一人死于心血管疾病。美国约有 695,000 人死于心臟病，即每 5 个人中就有 1 人死于心臟病。

此外，根据英国心臟基金会2023 的数据，全球约有6.2 亿人患有心臟病和循环系统疾病- 由于生活方式的改变、人口老龄化和人口增长以及心臟病生存率的提高，这一数字一直在上升和中风 - 如果这些趋势持续下去，将会继续上升。因此，心血管疾病的增加有助于推动市场的成长。此外，心血管输出监测仪可以为医疗保健专业人员提供做出明智决策和避免负面结果所需的信息，从而提高患者的安全性。监测技术的不断发展使得开发侵入性更小、更精确的心输出量监测工具成为可能，使其在临床环境中更加可用和有用。

限制

心输出量监测仪相关的高成本等因素预计将阻碍市场的发展。用于监测心输出量的设备，尤其是侵入式设备，购买和操作起来都可能很昂贵。由于高昂的前期成本以及消耗品或校准的经常性成本，它们的使用可能会受到阻碍，特别是在资源有限的医疗保健环境中。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 心血管设备的普及率不断提高
    • 限制
      • 与心输出量监视器相关的高成本
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 未满足的需求
  • PESTEL分析
  • 专利分析
  • SWOT分析

第 6 章：按类型

  • 有创心输出量监测仪
  • 非侵入性心输出量监测仪
  • 微创心输出量监测仪
  • 其他的

第 7 章：按技术

  • 肺动脉导管
  • 热稀释脉衝轮廓分析技术
  • 锂稀释技术
  • 动脉波形分析技术
  • 多普勒
  • 其他的

第 8 章：最终用户

  • 医院
  • 心臟中心
  • 门诊手术中心
  • 其他的

第 9 章：按地区

  • 北美洲
    • 按配销通路分類的规模分析和同比增长分析 (%)
      • 我们
      • 加拿大
      • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • Edwards Lifesciences Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Masimo
  • Getinge Inc.
  • Nihon Kohden Corporation
  • Deltex Medical Group plc
  • GE Healthcare
  • Koninklijke Philips NV
  • Schwarzer Cardiotek
  • Tenko Medical System Corp
  • Osypka Medical (*LIST NOT EXHAUSTIVE)

第 12 章：附录

简介目录
Product Code: MD7263

Overview

The global cardiac output monitors market reached US$ 1.5 billion in 2023 and is expected to reach US$ 2.23 billion by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031.

Cardiac output monitors play a crucial role in clinical medicine, particularly in critical care and cardiology settings, as they provide essential information about a patient's cardiovascular function. The importance of cardiac output monitoring lies in its ability to help healthcare providers make informed decisions regarding patient management and treatment. Cardiac output monitoring allows patient treatment strategies to be customized.

By adapting therapies to a patient's individual cardiovascular needs, medical professionals can optimize patient outcomes. Close cardiac output monitoring is frequently necessary for patients with heart failure in order to evaluate the efficacy of treatment and avoid decompensation. Organ failure, tissue hypoxia, and extended hospital stays can all be avoided with the early identification and treatment of hemodynamic instability.

Market Dynamics: Drivers

Increasing prevalence of cardiovascular diseases

The rising prevalence of cardiovascular diseases propels the market growth. Improved monitoring and management technologies, including cardiac output monitors, are required due to the rising prevalence of cardiovascular diseases and disorders. The market is expanding rapidly as a result of the rise in cardiovascular diseases. For instance, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 33 seconds in the United States from cardiovascular disease. About 695,000 people in the United States died from heart disease, that's 1 in every 5 deaths.

Moreover, according to the British Heart Foundation 2023, stated that around 620 million people live with heart and circulatory diseases across the world - this number has been rising due to changing lifestyles, an aging, and growing population, and improved survival rates from heart attacks and strokes - and will continue to rise if these trends continue. Thus rising of the cardiovascular diseases helps to drive the market growth. Additionally, cardiovascular output monitors improve patient safety by giving healthcare professionals the information they need to make wise decisions and avoid negative outcomes. The development of less invasive and more precise cardiac output monitoring tools has been made possible by ongoing developments in monitoring technology, making them more available and useful in clinical settings.

Restraints

Factors such as high costs associated with cardiac output monitors are expected to hamper the market. The devices for monitoring cardiac output, particularly invasive ones, can be pricey for both purchase and operation. Their use may be hindered, especially in healthcare settings with limited resources, due to high upfront costs and recurring costs for consumables or calibration.

Segment Analysis

The global cardiac output monitors market is segmented based on type, technology, end-user, and region.

The non-invasive cardiac output monitors accounted for approximately 46.7% of the global cardiac output monitors market share.

The non-invasive cardiac output monitors segment is expected to hold the largest market share over the forecast period. In this segment, the features and launches of new products would drive this market.

A patient's cardiovascular function can be evaluated with non-invasive cardiac output monitors without a need for invasive treatments. These monitors offer useful data on cardiac output, or the amount of blood the heart pumps each minute, as well as other associated hemodynamic parameters. For instance, using invasive procedures like catheterization is not necessary when using non-invasive monitoring techniques like impedance cardiography or Doppler ultrasonography. As a result, there is a lower possibility of problems, infections, and patient discomfort brought on by invasive monitoring methods.

They aid in the early detection of abnormalities in the heart function of a patient. Clinicians can see problems like heart failure exacerbations or shock states and act quickly by continually monitoring cardiac output and associated metrics. Moreover, on April 25, 2022, with the addition of cardiac output, stroke volume, heart rate variability, and left ventricular ejection time to its VitalStream non-invasive patient monitoring platform, Caretaker Medical, a provider of wireless patient monitoring technologies, received FDA 510(k) clearance.

Geographical Analysis

North America accounted for approximately 43.8% of the global cardiac output monitors market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of cardiovascular diseases, approvals, and increase in the healthcare expenses in this region, help to propel the market.

For instance, according to the National Institute of Health, approximately 82.6 million people in the United States currently have one or more forms of cardiovascular disease (CVD), making it a leading cause of death for both men and women. Common types of cardiovascular disease include coronary heart disease (CHD), stroke, hypertension, and congestive heart failure. An estimated 16.3 million Americans aged 20 and older have CHD, a prevalence of 7 percent.

The prevalence for men is 8.3 percent and for women is 6.1 percent. About 7 million Americans aged 20 or older have had a stroke. Each year approximately 610,000 experience their first stroke and another 185,000 experience a recurrence. Approximately 87 percent of all strokes are ischemic of which 10 percent result from intracerebral hemorrhage and 3 percent result from subarachnoid hemorrhage.

Market Segmentation

By Type

Invasive Cardiac Output Monitors

Non-Invasive Cardiac Output Monitors

Minimally Invasive Cardiac Output Monitors

Others

By Technology

Pulmonary Artery Catheter

Thermodilution Pulse Contour Analysis Technique

Lithium Dilution Technique

Arterial Waveform Analysis Technique

Doppler

Others

By End-User

Hospitals

Cardiac Centers

Ambulatory Surgical Centers

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Competitive Landscape

The major global players in the global cardiac output monitors market include Edwards Lifesciences Corporation, Masimo, Getinge Inc, Nihon Kohden Corporation, Deltex Medical Group plc, GE Healthcare, Koninklijke Philips N.V, Schwarzer Cardiotek, Tenko Medical System Corp, Osypka Medical among others.

Key Developments

In October 2023, Masimo announced the CE mark, under the European Union Medical Device Regulation, for the LiDCO(R) board-in-cable (BIC) module. The LiDCO BIC module is designed to connect to multi-patient monitoring platforms, like the Masimo Root(R) Patient Monitoring and Connectivity Hub, to provide advanced hemodynamic monitoring. With this solution, clinicians can easily add LiDCO hemodynamic monitoring

In April 2023, French medical device company, Vygon India launched its advanced hemodynamic monitoring system, Mostcare Up, in North India during a Society of Critical Care Medicine (ISCCM) symposium in Chandigarh. The Mostcare Up system is a minimally invasive arterial pressure-based monitor powered by a patented algorithm based on the Pressure Recording Analytical Method (PRAM). It is the only monitor that can follow even the slightest hemodynamic variations in real time and from beat to beat.

Why Purchase the Report?

To visualize the global cardiac output monitors market segmentation based on type, technology, end-user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global cardiac output monitors market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global cardiac output monitors market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Cardiovascular Devices
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost Associated with the Cardiac Output Monitors
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Invasive Cardiac Output Monitors *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Non-Invasive Cardiac Output Monitors
  • 6.4. Minimally Invasive Cardiac Output Monitors
  • 6.5. Others

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Pulmonary Artery Catheter *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Thermodilution Pulse Contour Analysis Technique
  • 7.4. Lithium Dilution Technique
  • 7.5. Arterial Waveform Analysis Technique
  • 7.6. Doppler
  • 7.7. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cardiac Centers
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Edwards Lifesciences Corporation *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Masimo
  • 11.3. Getinge Inc.
  • 11.4. Nihon Kohden Corporation
  • 11.5. Deltex Medical Group plc
  • 11.6. GE Healthcare
  • 11.7. Koninklijke Philips N.V
  • 11.8. Schwarzer Cardiotek
  • 11.9. Tenko Medical System Corp
  • 11.10. Osypka Medical (*LIST NOT EXHAUSTIVE)

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us